Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life
Article in Human Vaccines & Immunotherapeutics (May 2024)
The most recent citing publications are shown below. View all 177 publications that cite this research output on Dimensions.
Article in Human Vaccines & Immunotherapeutics (May 2024)
Article in Emergency Medicine Clinics of North America (May 2024)
Article in Journal of the American Veterinary Medical Association (March 2024)